Lymph node mapping and curability at various levels of metastasis in resected lung cancer
- PMID: 713589
Lymph node mapping and curability at various levels of metastasis in resected lung cancer
Abstract
By means of lymph mapping, the prognosis significance of lymph node metastasis in lung cancer was studied in 270 patients who had undergone radical operations--pulmonary resection combined with complete mediastinal lymph node disection, which is used for patients in whom all cancer could thereby be ablated. Mediastinal lymph node metastasis was found in 64 patients, and 12 patients lived 5 years or more (an absolute 5 year survival rate of 18.8 percent). After radical surgery, there was a significant difference between the prognosis for patients who had metastases to the subcrainal lymph nodes as compared to the prognosis for those who did not. The 5 years survival rates were 9.1 percent and 29.0 percent, respectively. On the other hand, prognosis was not significantly affected by involvement or noninvolvement of the superior mediastinal, paratracheal, tracheobronchial, pretracheal, and the subaortic and para-aortic lymph nodes. No significant difference in survival was detected between patients who were given adjuvant therapy and those who were not. Lymph node mapping gives valuable prognostic information.
Similar articles
-
The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.Eur J Cardiothorac Surg. 2006 Sep;30(3):543-7. doi: 10.1016/j.ejcts.2006.05.024. Epub 2006 Jul 25. Eur J Cardiothorac Surg. 2006. PMID: 16870462
-
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077. Ann Thorac Surg. 2006. PMID: 16368383
-
Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer.Eur J Cardiothorac Surg. 2007 Feb;31(2):167-72. doi: 10.1016/j.ejcts.2006.11.004. Epub 2006 Dec 5. Eur J Cardiothorac Surg. 2007. PMID: 17150367
-
[Lymph node clearance].Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S101-5. Rev Mal Respir. 2005. PMID: 16340844 Review. French.
-
[The role of systemic therapy of lung metastases with lymph node involvement].Chirurg. 2019 Dec;90(12):997-1002. doi: 10.1007/s00104-019-01045-1. Chirurg. 2019. PMID: 31745581 Review. German.
Cited by
-
Imaging of lung cancer: Implications on staging and management.Indian J Radiol Imaging. 2015 Apr-Jun;25(2):109-20. doi: 10.4103/0971-3026.155831. Indian J Radiol Imaging. 2015. PMID: 25969634 Free PMC article.
-
Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.Gen Thorac Cardiovasc Surg. 2009 Nov;57(11):599-604. doi: 10.1007/s11748-009-0451-z. Epub 2009 Nov 12. Gen Thorac Cardiovasc Surg. 2009. PMID: 19908114
-
New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.Thorac Cancer. 2019 Dec;10(12):2253-2258. doi: 10.1111/1759-7714.13213. Epub 2019 Oct 16. Thorac Cancer. 2019. PMID: 31617316 Free PMC article.
-
[Role of mediastinoscopy and repeat mediastinoscopy today].Chirurg. 2008 Jan;79(1):38, 40-4. doi: 10.1007/s00104-007-1447-9. Chirurg. 2008. PMID: 18209980 Review. German.
-
Prognostic value of different N1 lymph node zones in pN1M0 non-small cell lung cancer: a systematic review and meta-analysis.Sci Rep. 2021 Nov 3;11(1):21606. doi: 10.1038/s41598-021-01136-2. Sci Rep. 2021. PMID: 34732794 Free PMC article.